Skip to main navigation Skip to search Skip to main content

Provider and site-level determinants of testosterone prescribing in the veterans healthcare system

  • Guneet K. Jasuja*
  • , Shalender Bhasin
  • , Adam J. Rose
  • , Joel I. Reisman
  • , Joseph T. Hanlon
  • , Donald R. Miller
  • , Anthony P. Morreale
  • , Leonard M. Pogach
  • , Francesca E. Cunningham
  • , Angela Park
  • , Renda S. Wiener
  • , Allen L. Gifford
  • , Dan R. Berlowitz
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Context: Testosterone prescribing rates have increased substantially in the past decade. However, little is known about the context within which such prescriptions occur. Objective: We evaluated provider- and site-level determinants of receipt of testosterone and of guideline-concordant testosterone prescribing. Design: This study was cross-sectional in design. Setting: This study was conducted at the Veterans Health Administration (VA). Participants: Study participants were a national cohort of male patients who had received at least one outpatient prescription within the VA during fiscal year (FY) 2008 to FY 2012. A total of 38,648 providers and 130 stations were associated with these patients. Main Outcome Measure: This study measured receipt of testosterone and guideline-concordant testosterone prescribing. Results: Providers ranging in age from 31 to 60 years, with less experience in the VA [all adjusted odds ratio (AOR),2; P,0.01] and credentialed as medical doctors in endocrinology (AOR, 3.88; P, 0.01) and urology (AOR, 1.48; P , 0.01) were more likely to prescribe testosterone compared with older providers, providers of longer VA tenure, and primary care providers, respectively. Sites located in the West compared with the Northeast [AOR, 1.75; 95% confidence interval (CI), 1.45-2.11] and care received at a community-based outpatient clinic compared with a medical center (AOR, 1.22; 95% CI, 1.20-1.24) also predicted testosterone use. Although they weremorelikely to prescribe testosterone, endocrinologists were also more likely to obtain an appropriate workup before prescribing compared with primary care providers (AOR, 2.14; 95% CI, 1.54-2.97). Conclusions: Our results highlight the opportunity to intervene at both the provider and the site levels to improve testosterone prescribing. This study also provides a useful example of how to examine contributions to prescribing variation at different levels of the health care system.

Original languageEnglish
Pages (from-to)3226-3233
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume102
Issue number9
DOIs
StatePublished - 1 Sep 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2017 Endocrine Society.

Fingerprint

Dive into the research topics of 'Provider and site-level determinants of testosterone prescribing in the veterans healthcare system'. Together they form a unique fingerprint.

Cite this